Placental trophoblast infection and TLR mediated response to congenital CMV

胎盘滋养层感染和 TLR 介导的先天性 CMV 反应

基本信息

项目摘要

DESCRIPTION (provided by applicant): Development of an effective intervention strategy against congenital cytomegalovirus (CMV) is a major public health priority. However, candidate CMV vaccines strategies have been unsuccessful in completely preventing congenital infection in a pre-clinical animal model and an effective vaccine remains an elusive goal. The pathogenicity of CMV transplacental infection is poorly defined and a better understanding may provide fresh insight for the development of a novel intervention or vaccine strategy. In this proposal, we will examine two key aspects of placental infection: (1) Toll-like receptor (TLR) mediated innate immune response of the placenta to CMV; (2) Viral tropism and placental infection. The inflammatory innate immune response mediated via TLRs expressed on key placental cells (trophoblasts) is potentially an important aspect of controlling placental invasion congenital infection by both bacteria and viruses. CMV is known to be recognized by multiple TLRs but the placental TLR mediated response to CMV is poorly defined as is the mechanism by which CMV potentially circumvents the placental innate immunity and infects the fetus in utero. It is our hypothesis that successful congenital infection is reliant upon the ability of CMV to efficiently enter and usurp TLR expressing trophoblast cells, an important component of the placental barrier and placental innate immunity. Potentially, the newly identified endocytic pathway of viral cell entry could be an important factor in the invasion of the placenta and infection of epithelial trophoblasts. We propose to determine the significance of the TLR mediated innate immune response of the placenta to CMV infection in the only small animal model (guinea pig) for congenital CMV. Additionally, using the same animal model, we will define important tropism genes that potentially enable the virus to establish infectious foci in th placenta and subsequently infect the fetus in utero. These studies will employ conventional histopathological and immunohistochemical approaches as well as novel techniques including the use of bioluminescence imaging of viral dissemination in the animal model.
描述(由申请人提供):开发有效的干预策略来预防先天性巨细胞病毒(CMV)是一项重要的公共卫生优先事项。然而,在临床前动物模型中,候选CMV疫苗策略在完全预防先天性感染方面一直不成功,有效的疫苗仍然是一个难以实现的目标。CMV经胎盘感染的致病性尚不明确,更好的理解可能会为开发新的干预措施或疫苗策略提供新的见解。在这个提案中,我们将研究胎盘感染的两个关键方面:(1)Toll样受体(TLR)介导的胎盘对CMV的先天免疫反应;(2)病毒嗜性和胎盘感染。胎盘关键细胞(滋养层细胞)上表达的TLRs介导的炎性先天免疫反应是控制细菌和病毒先天性感染胎盘侵袭的一个重要方面。已知CMV可被多个TLR识别,但胎盘TLR介导的对CMV的应答尚不清楚,CMV潜在地绕过胎盘天然免疫并在宫内感染胎儿的机制尚不清楚。我们的假设是,成功的先天性感染依赖于CMV的能力 为了有效地进入和篡夺表达TLR的滋养层细胞,滋养层细胞是胎盘屏障和胎盘先天免疫的重要组成部分。新近发现的病毒进入细胞的内吞途径可能是导致胎盘侵入和滋养层细胞感染的重要因素。我们建议在唯一的先天性巨细胞病毒小动物模型(豚鼠)中,确定TLR介导的胎盘对巨细胞病毒感染的先天免疫反应的意义。此外,使用相同的动物模型,我们将定义重要的趋向性基因,这些基因可能使病毒在胎盘中建立感染灶,并随后感染子宫内的胎儿。这些研究将使用传统的组织病理学和免疫组织化学方法以及新技术,包括使用动物模型中病毒传播的生物发光成像。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALISTAIR MCGREGOR其他文献

ALISTAIR MCGREGOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALISTAIR MCGREGOR', 18)}}的其他基金

Development of a universal DISC vaccine strategy against congenital cytomegalovirus
针对先天性巨细胞病毒的通用 DISC 疫苗策略的开发
  • 批准号:
    10386763
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Development of a universal DISC vaccine strategy against congenital cytomegalovirus
针对先天性巨细胞病毒的通用 DISC 疫苗策略的开发
  • 批准号:
    10595098
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
Development of a universal DISC vaccine strategy against congenital cytomegalovirus
针对先天性巨细胞病毒的通用 DISC 疫苗策略的开发
  • 批准号:
    10096812
  • 财政年份:
    2021
  • 资助金额:
    $ 37.12万
  • 项目类别:
CMV pentameric complex based vaccine strategies for prevention of congenital CMV
基于 CMV 五聚体复合物的预防先天性 CMV 的疫苗策略
  • 批准号:
    9382991
  • 财政年份:
    2017
  • 资助金额:
    $ 37.12万
  • 项目类别:
CMV pentameric complex based vaccine strategies for prevention of congenital CMV
基于 CMV 五聚体复合物的预防先天性 CMV 的疫苗策略
  • 批准号:
    10162628
  • 财政年份:
    2017
  • 资助金额:
    $ 37.12万
  • 项目类别:
Vaccine against CMV endothelial tropism & congenital infection
抗 CMV 内皮趋向性疫苗
  • 批准号:
    8240627
  • 财政年份:
    2012
  • 资助金额:
    $ 37.12万
  • 项目类别:
Placental trophoblast infection and TLR mediated response to congenital CMV
胎盘滋养层感染和 TLR 介导的先天性 CMV 反应
  • 批准号:
    8890099
  • 财政年份:
    2012
  • 资助金额:
    $ 37.12万
  • 项目类别:
Development of an effective DISC vaccine strategy against congenital CMV
开发针对先天性 CMV 的有效 DISC 疫苗策略
  • 批准号:
    8270164
  • 财政年份:
    2012
  • 资助金额:
    $ 37.12万
  • 项目类别:
Development of an effective DISC vaccine strategy against congenital CMV
开发针对先天性 CMV 的有效 DISC 疫苗策略
  • 批准号:
    8685114
  • 财政年份:
    2012
  • 资助金额:
    $ 37.12万
  • 项目类别:
Vaccine against CMV endothelial tropism & congenital infection
抗 CMV 内皮趋向性疫苗
  • 批准号:
    8424944
  • 财政年份:
    2012
  • 资助金额:
    $ 37.12万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 37.12万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 37.12万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了